REDECT

Renal Masses: Pivotal Trial To Detect clear-cell RCC with pre-surgical PET/CT. REDECT is a Phase III trial, which will evaluate whether imaging with REDECTANE® can improve the diagnosis in comparison to the current standard (CT)

Seite gelesen: 387 | Heute: 7
Seite gelesen: 388 | Heute: 8